Email Michael Daniels

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Long Term Investor Notice: Investigation of Potential Wrongdoing

Certain directors of AcelRx Pharmaceuticals, Inc. are under investigation concerning potential breaches of fiduciary duties.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy